Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Extracellular matrix collagen synthesis stimulation" describes the process by which cellular pathways and factors—most notably via activated fibroblasts and key signaling molecules like TGF-β—lead to increased biosynthesis of collagen, a fundamental structural protein in the extracellular matrix[1][2][6]. Collagen synthesis occurs primarily in fibroblasts, involving a multistep process including gene transcription, translation, post-translational modifications, and secretion, culminating in the extracellular assembly of collagen fibrils[2][3]. This process is central to tissue homeostasis, wound repair, fibrotic diseases, and cancer progression due to its role in extracellular matrix remodeling[1][6]. "Stimulation" refers to the upregulation of these processes, typically in response to cytokines or growth factors such as TGF-β[1]. Due to its centrality to multiple physiological and pathological conditions, many drug targets act upstream or downstream of this pathway, but "extracellular matrix collagen synthesis stimulation" itself is a process and not a druggable entity[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular matrix collagen synthesis stimulation.